TRAIL (TNF-related apoptosis-inducing ligand) induces necrosis-like cell death in tumor cells at acidic extracellular pH

Annals of the New York Academy of Sciences

Volumn 1056, Issue , 2005, Pages 379-387

  Meurette, Olivier ^a   Huc, Laurence ^a   Rebillard, Amelie ^a   Le Moigne, Gwenaelle ^a   Lagadic Gossmann, Dominique ^a   Dimanche Boitrel, Marie Therese ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Apoptosis; Colon cancer cells; Hepatocarcinoma cells; Human primary hepatocytes; Necrosis; pH; TRAIL

Indexed keywords

BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; PROTEIN BCL 2; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN TRAIL; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ACIDITY; APOPTOSIS; CELL DEATH; CELL PH; CELL SPECIFICITY; COLON CARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MICROENVIRONMENT; PROTEIN EXPRESSION; PROTEIN INDUCTION; TUMOR CELL CULTURE;

EID: 29744470172     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1352.018     Document Type: Conference Paper

References (26)

1. ASHKENAZI, A., R.C. PAI, S. FONG, et al. 1999. Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. 104: 155-162.
2. WALCZAK, H., R.E. MILLER, K. ARIAIL, et al. 1999. Tumoricidal activity of tumor necrosis factor-related apoptosis- inducing ligand in vivo. Nat. Med. 5: 157-163.
3. ZIMMERMANN, K.C. & D.R. GREEN. 2001. How cells die: apoptosis pathways. J. Allergy Clin. Immunol. 108: S99-103.
4. ASHKENAZI, A. 2002. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat. Rev. Cancer 2: 420-430.
5. SCAFFIDI, C., S. FULDA, A. SRINIVASAN, et al. 1998. Two CD95 (APO-1/Fas) signaling pathways. Embo J. 17: 1675-1687.
6. LI, H., H. ZHU, C.J. XU, et al. 1998. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501.
7. KROEMER, G. & J.C. REED. 2000. Mitochondrial control of cell death. Nat. Med. 6: 513-519.
8. ZHANG, L. & B. FANG. 2005. Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther. 2: 228-237.
9. WIKE-HOOLEY, J.L., A.P. VAN DEN BERG, J. VAN DER ZEE, et al. 1985. Human tumour pH and its variation. Eur. J. Cancer Clin. Oncol. 21: 785-791.
10. LAGADIC-GOSSMANN, D., L. Hue & V. LECUREUR. 2004. Alterations of intracellular pH homeostasis in apoptosis: origins and roles. Cell Death Differ. 11: 953-961.
11. LACOUR, S., O. MICHEAU, A. HAMMANN, et al. 2003. Chemotherapy enhances TNF-related apoptosis-inducing ligand DISC assembly in HT29 human colon cancer cells. Oncogene 22: 1807-1816.
12. GUGUEN-GUILLOUZO, C., J.P. CAMPION, P. BRISSOT, et al. 1982. High yield preparation of isolated human adult hepatocytes by enzymatic perfusion of the liver. Cell Biol. Int. Rep. 6: 625-628.
13. BUCKLER, K.J. & R.D. VAUGHAN-JONES. 1990. Application of a new pH-sensitive fluoroprobe (carboxy-SNARF-1) for intracellular pH measurement in small, isolated cells. Pflugers Arch. 417: 234-239.
14. LAGADIC-GOSSMANN, D., M. RISSEL, M. GALISTEO, et al. 1999. Intracellular pH alterations induced by tacrine in a rat liver biliary epithelial cell line. Br. J. Pharmacol. 128: 1673-1682.
15. KOZIN, S.V., P. SHKARIN & L.E. GERWECK. 2001. The cell transmembrane pH gradient in tumors enhances cytotoxicity of specific weak acid chemotherapeutics. Cancer Res. 61:4740-4743.
16. TANNOCK, I.F. & D. ROTIN. 1989. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 49: 4373-4384.
17. RAGHUNAND, N. & R.J. GILLIES. 2001. pH and chemotherapy. Novartis Found. Symp. 240: 199-211; discussion 265-198.
18. LEE, Y.J., J.J. SONG, J.H. KIM, et al. 2004. Low extracellular pH augments TRAlL-induced apoptotic death through the mitochondria-mediated caspase signal transduction pathway. Exp. Cell Res. 293: 129-143.
19. WANG, X., S.W. RYTER, C. DAI, et al. 2003. Necrotic cell death in response to oxidant stress involves the activation of the apoptogenic caspase-8/bid pathway. J. Biol. Chem. 278: 29184-29191.
20. PROSKURYAKOV, S.Y., A.G. KONOPLYANNIKOV & V.L. GABAI. 2003. Necrosis: a specific form of programmed cell death? Exp. Cell Res. 283: 1-16.
21. KEMP, T.J., J.S. KIM, S.A. CRIST, et al. 2003. Induction of necrotic tumor cell death by TRAIL/Apo-2L. Apoptosis 8: 587-599.
22. DENECKER, G., D. VERCAMMEN, W. DECLERCQ, et al 2001. Apoptotic and necrotic cell death induced by death domain receptors. Cell Mol. Life Sci. 58: 356-370.
23. HOLLER, N., R. ZARU, O. MICHEAU, et al. 2000. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 1:489-495.
24. JAATTELA, M. 2004. Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene 23: 2746-2756.
25. LEIST, M. & M. JAATTELA. 2001. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. 2: 589-598.
26. IZUMI, H., T. TORIGOE, H. ISHIGUCIII, et al. 2003. Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. Cancer Treat. Rev. 29: 541-549.